The National Cancer Institute, an agency of the federal government, now lists on its website recent studies showing marijuana kills cancer cells. Meanwhile, the Drug Enforcement Agency continues to oppose any and all efforts to remove cannabis from Schedule I of the Controlled Substances Act, claiming it has “no currently accepted medical use.”
According to NCI, preclinical studies of cannabinoids have shown:
- Cannabinoids can kill cancer cells in animals while protecting normal cells.
- Cannabinoids protects against colon inflammation and may potentially reduce the risk of colon cancer in mice.
- In a laboratory study of delta-9-THC in hepatocellular carcinoma (liver cancer) cells showed that cannabinoids damaged or killed the cancer cells. The same study of delta-9-THC in mouse models of liver cancer showed that it had antitumor effects. Delta-9-THC has been shown to cause these effects by acting on molecules that may also be found in non-small cell lung cancer cells and breast cancer cells.
- In a laboratory study of cannabidiol (CBD) in estrogen receptor positive and estrogen receptor negative breast cancer cells, CBD was shown to have caused cancer cell death while having little effect on normal breast cells. Studies in mouse models of metastatic breast cancer showed that cannabinoids may lessen the growth, number, and spread of tumors.
- A laboratory study of cannabidiol (CBD) in human glioma cells showed that when given along with chemotherapy, CBD may make chemotherapy more effective and increase cancer cell death without harming normal cells. Studies in mouse models of cancer showed that CBD together with delta-9-THC may make chemotherapy such as temozolomide more effective.
- In animal studies, delta-9-THC and other cannabinoids have been shown to stimulate appetite and can increase food intake. Reduced appetite is a common problem experienced by chemotherapy patients.
- Cannabinoids may prevent nerve problems (pain, numbness, tingling, swelling, and muscle weakness) caused by some types of chemotherapy, according to animal studies.
- Cannabinoid receptors found in brain cells may have a role in controlling nausea and vomiting. Animal studies have shown that delta-9-THC and other cannabinoids may act on cannabinoid receptors to prevent vomiting caused by certain types of chemotherapy.
I told you last January how the federal government argued and continues to argue that marijuana is a dangerous drug with no medicinal value even while it patents marijuana extracts for health-related uses and as it was posed to grant a license to GW Pharmaceuticals for treating patients with multiple sclerosis with a cannabinoid-based drug called Epidiolex.
Cannabis marijuana medications have also been used with complete safety for the treatment of many health problems, including asthma, glaucoma, nausea, tumors, epilepsy, infection, stress, migraines, anorexia, depression, rheumatism and arthritis.
The NCI website claims, “No clinical trials of Cannabis as a treatment for cancer in humans have been found in the CAM on PubMed database maintained by the National Institutes of Health.” Yet, PubMed, aka the National Institutes of Health, aka another government agency, lists a number of studies that have been conducted. Also, the Schedule I listing severely limits or prohibits the ability of most research organizations to hold clinical trails.
The truth is, marijuana and its uses have been studied far more than most drugs the FDA approves for use on the general public – drugs that cure nothing but merely cover symptoms and generate billions of dollars for Big Pharma.
The federal government – and most local governments — is far more interested in using marijuana as a revenue stream in its fake “War on Drugs” than in allowing medical marijuana in its many forms to improve the lives of people with health problems.
All the “War on Drugs” has accomplished is to create suffering and death, a large prison population, a host of people with criminal records for victimless crimes, a more militarized police regime and great loss of liberty.